Cell-Free Method of Producing Synthetic Circular Nucleic Acid
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,509,719 | Cell-Free Method of Producing Synthetic Circular Nucleic Acid In force · Medium confidence | Aldevron, L.L.C. | In force | Medium confidence | ||
| Application 19/398,303 | Cell-Free Method of Producing Synthetic Circular Nucleic Acid Pending Not granted | Aldevron, L.L.C. | Pending | Not granted |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Aldevron, LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.